Funding profile · Digital pharmacy, Latin America

FastFarma

A Y Combinator backed Ecuadorian pharmacy delivery startup that raised at least $125,000 plus an undisclosed round from a small group of named investors, then closed operations in every market in December 2022. No SEC Form D was ever filed for it.

$125KY Combinator investment, 2021, reported by Forbes Ecuador
UndisclosedAdditional 2021 round; founders declined to state the amount
4Named investors on record: BuenTrip Ventures, Y Combinator, Axial VC, Magma Partners
$0SEC Form D filings found for FastFarma on EDGAR

Data as of September 25, 2026. Company-reported and press-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
By Sep 2021 Y Combinator investment, Summer 2021 batch $125,000 Y Combinator Press report
2021 Additional round, size undisclosed Not disclosed Not named; the founders told Forbes Ecuador they preferred to keep the amount anonymous Press report
Undated, pre-2022 Early backers named in deal-tracking data Not disclosed BuenTrip Ventures, Axial VC Deal-tracking data
Jun 16, 2022 Investment recorded in deal-tracking data Not disclosed Magma Partners Deal-tracking data
Dec 2022 Wind-down: capital to be returned to investors, per company communique Not disclosed All prior investors, per the communique Press report

What the filings show

No Form D appears for FastFarma or Fastfarma on SEC EDGAR. A company search on EDGAR for “fastfarma” returns no matching companies as of September 25, 2026. That is expected for a company that never raised from US investors through a Regulation D offering registered in its own name, and it means every dollar figure below comes from press reporting or deal-tracking sites, not from a federal filing.

Reading the numbers

  1. The clearest number is small.The only figure with a specific dollar amount tied to a source is Y Combinator’s $125,000 investment, reported by Forbes Ecuador in January 2022. Everything else raised by FastFarma, an additional 2021 round and later checks from named funds, is undisclosed in public reporting.
  2. The last recorded investment sits close to the shutdown.Deal-tracking site Parsers.vc lists a Magma Partners investment dated June 16, 2022, about six months before FastFarma’s December 2022 communique announcing it was closing in every market and returning capital to investors.
  3. No federal filing checks any of it.An EDGAR company search for “fastfarma” returns no matching companies, so the $125,000 figure, the undisclosed additional round, and the identities of BuenTrip Ventures, Axial VC and Magma Partners as investors rest entirely on press coverage and third-party deal-tracking data, not on a Form D or any other SEC record.
  4. Announced growth and a later revenue estimate do not reconcile.Forbes Ecuador reported about $300,000 in full year 2021 revenue, growing 40% a month by January 2022, with the founders expecting to beat that total in the first four months of 2022. A GetLatka estimate instead shows $2.9 million in revenue and 19 employees for 2024, two years after the company said it had closed operations in every market. No source resolves the gap.
  5. The company said it would return capital, not that it lost it.The December 2022 communique specifically promised to “devolver el capital a los inversionistas,” language describing a wind-down with repayment rather than a bankruptcy. No public record shows how much was returned, to whom, or when.

Commercial signals

Signal Detail Source type
Funding $125,000 from Y Combinator plus an undisclosed additional round, both in 2021. Independent
Revenue, 2021 About $300,000 for the full year, 30% from the Mexico City operation, growing 40% monthly by Jan 2022. Independent
Revenue, Sep 2021 About $20,000 in monthly revenue at the time of Y Combinator’s Summer 2021 Demo Day. Independent
Headcount 35 people across Ecuador and Mexico by Jan 2022, per Forbes Ecuador. Y Combinator lists a final team size of 8. Differs across sources
Status Y Combinator lists FastFarma as Inactive. The company’s own communique announced closure of operations in all markets, Dec 2022. Public record

What to watch

  • Any dissolution or liquidation record for Fastfarma S.A.S. with Ecuador’s Superintendencia de Compañías. None was located in this research.
  • Whether BuenTrip Ventures, Axial VC or Magma Partners disclose the outcome of their FastFarma position, including whether capital was in fact returned.
  • Any correction to GetLatka’s post-2022 revenue and headcount estimates for the company.

The FastFarma story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • NimbleRx: Also in Consumer Health and Wellness. Nimble began as a licensed dispensing pharmacy with its own stores, shut them in early 2019, and rebuilt itself as the software layer sold to the independent pharmacies
  • Digi-Prex: Also in Consumer Health and Wellness. A WhatsApp-first subscription pharmacy for chronic disease patients in Hyderabad, funded in one of India’s largest 2019 seed rounds
  • Mark Cuban Cost Plus Drug Company: Also in Consumer Health and Wellness. A Dallas public benefit corporation that publishes what it pays for every generic drug it sells, adds a fixed 15 percent, and now fills sterile injectables of its own
  • AIOS: Also in Consumer Health and Wellness. A San Francisco company that built its business running GLP-1 telehealth brands like Fella Health and Bolt Pharmacy, and in 2026 started pitching itself as something

Sources

  1. Public recordEDGAR company search, “fastfarma,” Form DSEC · accessed Sep 25, 2026
  2. Public recordFastFarma company profile, status InactiveY Combinator · accessed Sep 25, 2026
  3. Public recordFastfarma S.A.S. company profileEMIS · updated Mar 9, 2026
  4. IndependentReceta de exportación, una startup ecuatoriana creceForbes Ecuador, Pedro Maldonado Ordóñez · Jan 3, 2022
  5. IndependentStartups sufren golpe por escasez de fondos para financiarsePrimicias, Gabriela Coba · Dec 7, 2022
  6. IndependentHere are all the companies from Day 2 of Y Combinator’s Summer 2021 Demo DayTechCrunch · Sep 1, 2021
  7. IndependentFastFarma company and investor listingParsers.vc · accessed Sep 25, 2026
  8. IndependentFastFarma Revenue 2024: $2.9M Est. ARRGetLatka · accessed Sep 25, 2026, data labeled as of Aug 10, 2026
  9. CompanyPortfolio: FastFarmaMagma Partners · accessed Sep 25, 2026

Compiled from SEC records and published reports as of September 25, 2026. Form D notices report offerings under Regulation D; no such filing was found for FastFarma. Healthcare Venture Capital Fund holds no position in FastFarma. This page is not an offer to sell or a recommendation to buy any security.